Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phathom Pharmaceuticals (PHAT) Inventory (2023 - 2025)

Historic Inventory for Phathom Pharmaceuticals (PHAT) over the last 3 years, with Q3 2025 value amounting to $3.6 million.

  • Phathom Pharmaceuticals' Inventory rose 1607.2% to $3.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.6 million, marking a year-over-year increase of 1607.2%. This contributed to the annual value of $3.2 million for FY2024, which is 16556.29% up from last year.
  • Phathom Pharmaceuticals' Inventory amounted to $3.6 million in Q3 2025, which was up 1607.2% from $3.4 million recorded in Q2 2025.
  • Phathom Pharmaceuticals' 5-year Inventory high stood at $3.6 million for Q3 2025, and its period low was $111000.0 during Q2 2023.
  • In the last 3 years, Phathom Pharmaceuticals' Inventory had a median value of $2.6 million in 2024 and averaged $2.2 million.
  • Its Inventory has fluctuated over the past 5 years, first soared by 270270.27% in 2024, then soared by 1607.2% in 2025.
  • Phathom Pharmaceuticals' Inventory (Quarter) stood at $1.2 million in 2023, then surged by 165.56% to $3.2 million in 2024, then rose by 12.56% to $3.6 million in 2025.
  • Its Inventory stands at $3.6 million for Q3 2025, versus $3.4 million for Q2 2025 and $3.2 million for Q1 2025.